NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies
- PMID: 12831293
- DOI: 10.2165/00002512-200320090-00006
NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies
Abstract
Background: The relationship between NSAID use and gastrointestinal (GI) symptoms and their treatment in elderly patients is not well defined.
Objectives: To identify the prevalence of specific drug use in elderly outpatients and to identify the relationship between NSAID use and GI disturbances and treatments in elderly subjects treated by their general practitioner (GP).
Setting and participants: The study was carried out by 63 GPs in north-eastern Italy; 3154 elderly subjects were included in the study over a 2-week period.
Design: By using a structured interview, subjects' medical histories and current medication were identified. In particular, the presence and use pattern (i.e. occasional, 'acute' or 'chronic') of NSAIDs and/or aspirin (acetylsalicylic acid) were recorded. In all subjects, the presence of upper GI symptoms, i.e. abdominal pain, reflux symptoms and indigestion syndrome, were noted.
Results: The prevalence of drug use was 96.4% (males 96%, females 96.7%). The most prescribed drugs were ACE inhibitors (38%), diuretics (26.7%), NSAIDs and regular-dose aspirin (24.7%), GI drugs (20.6%), and anxiolytics/hypnotics (20.3%). Of 779 subjects who had taken NSAIDs or regular-dose aspirin, 32.9% were 'chronic' users, 24.9% were 'acute' users and 42.1% occasional users. A significantly higher prevalence of upper GI symptoms was observed in elderly NSAID and low-dose aspirin users compared with non-users (24.9% vs 28% vs 16.6% respectively, p < 0.0001). GI symptoms were reported by 27.6% of 'chronic' NSAID users, 22.9% of 'acute' users and 24.7% of occasional users. A significantly higher prescription rate for any GI drug was found in NSAID users than in low-dose aspirin users and non-users (24.0% vs 19.6% vs 19.4% respectively, p = 0.007). This difference was mainly because of a higher number of upper GI drugs taken by NSAID users than by low-dose aspirin users and non-users (18.1% vs 16% vs 13.7% respectively, p = 0.004). Multivariate analysis demonstrated that female gender (odds ratio [OR] = 1.32, 95% CI = 1.16-1.44), low-dose aspirin (OR = 1.88, 95% CI = 1.33-2.65), NSAIDs and/or regular-dose aspirin (OR = 1.48, 95% CI = 1.19-1.83) and multiple therapies, i.e. taking more than four drugs per day (OR = 1.42, 95% CI = 1.14-1.77) were risk factors for GI symptoms in elderly outpatients.
Conclusion: NSAIDs and/or aspirin use was very high in this elderly outpatient population. The use of these drugs was significantly associated with a greater number of upper GI symptoms and prescriptions for GI drugs. Educational and clinical strategies need to be implemented in order to reduce the GI impact of NSAID and aspirin use in elderly people.
Similar articles
-
Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.Aliment Pharmacol Ther. 2005 Jul 15;22(2):147-55. doi: 10.1111/j.1365-2036.2005.02537.x. Aliment Pharmacol Ther. 2005. PMID: 16011673
-
The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.Aging Clin Exp Res. 2003 Dec;15(6):494-9. doi: 10.1007/BF03327372. Aging Clin Exp Res. 2003. PMID: 14959953
-
Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.Clin Drug Investig. 2008;28(11):687-95. doi: 10.2165/00044011-200828110-00002. Clin Drug Investig. 2008. PMID: 18840011
-
Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly.Drugs Aging. 2007;24(2):121-31. doi: 10.2165/00002512-200724020-00004. Drugs Aging. 2007. PMID: 17313200 Review.
-
Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?Rev Gastroenterol Disord. 2004;4 Suppl 4:S33-41. Rev Gastroenterol Disord. 2004. PMID: 15580145 Review.
Cited by
-
Pattern of NSAID use in the Italian general population: a questionnaire-based survey.Eur J Clin Pharmacol. 2004 Dec;60(10):731-8. doi: 10.1007/s00228-004-0826-0. Epub 2004 Oct 26. Eur J Clin Pharmacol. 2004. PMID: 15517225
-
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.Front Pharmacol. 2021 Jun 21;12:684162. doi: 10.3389/fphar.2021.684162. eCollection 2021. Front Pharmacol. 2021. PMID: 34234675 Free PMC article. Review.
-
Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.Open Access Rheumatol. 2013 Feb 26;5:1-19. doi: 10.2147/OARRR.S41420. eCollection 2013. Open Access Rheumatol. 2013. PMID: 27790020 Free PMC article.
-
Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Br J Clin Pharmacol. 2004 Nov;58(5):452-69. doi: 10.1111/j.1365-2125.2004.02228.x. Br J Clin Pharmacol. 2004. PMID: 15521892 Free PMC article. Review. No abstract available.
-
Challenges associated with peripheral arterial disease in women.Vasc Health Risk Manag. 2014 Mar 10;10:115-28. doi: 10.2147/VHRM.S45181. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24648743 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous